|
|
|
|
Once-Daily Sofosbuvir With GS-5816 for
8 Weeks With or Without Ribavirin in Patients
With HCV Genotype 3 Without Cirrhosis
Result in High Rates of SVR12:
The ELECTRON-2 Study
|
|
|
Reported by Jules Levin
AASLD 2014 Boston Nov 8-11
Edward J. Gane1, Robert H. Hyland2, Di An2, Evguenia Svarovskaia2,
John McNally2, Diana M. Brainard2, William T. Symonds2,
John G. McHutchison2, Catherine A. Stedman3
1Auckland Clinical Studies, Auckland, New Zealand; 2Gilead Sciences, Inc.,
Foster City, CA; 3Christchurch Clinical Studies Trust, Christchurch, New Zealand
|
|
|
|
|
|
|